TIMP-1在内分泌疾病中作用的研究进展OA

The biological effects of tissue inhibitor of matrix metalloproteinase-1(TIMP-1)in the endocrine system have attracted increasing research attention in recent years.As a core mediator of the endocrine-matrix interaction network,TIMP-1 is a key regulator of extracellular matrix(ECM)remodeling and plays a critical role in the occurrence and progression of endocrine diseases.However,its specific mechanisms of action have not yet been fully elucidated.Clarifying the mechanisms underlying the involvement of TIMP-1 in endocrine diseases and evaluating its potential clinical applications are therefore of considerable importance for improving the diagnosis and treatment of these disorders.TIMP-1 is closely associated with the onset and progression of several endocrine diseases,particularly diabetes mellitus,thyroid cancer,pituitary adenoma,and obesity.During the progression of diabetes mellitus,TIMP-1 may contribute to complications involving organs such as the eyes,kidneys,and intestines.In obesity,TIMP-1 is closely associated with chronic low-grade inflammation.In thyroid cancer and pituitary adenoma,TIMP-1 inhibits the activity of matrix metalloproteinases(MMPs),thereby reducing ECM degradation and basement membrane disruption;this preservation of barrier integrity may contribute to antitumor effects.TIMP-1 may therefore represent a potential therapeutic target for endocrine diseases.